Pharmosa Biopharm (ROCO:6875) Defensive Interval Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6875 Pharmosa Biopharm Inc ROCO:6875
27 GF Score
Price NT$33.00
GF Value NT$15.32
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Pharmosa Biopharm Defensive Interval Ratio?

ROCO:6875
27GF Score
Pharmosa Biopharm Inc ROCO:6875
Defensive Interval Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pharmosa Biopharm (ROCO:6875) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmosa Biopharm stock appears to be overvalued. The current stock price of NT$33.00 is trading 115.4% above its estimated GF Value™ of NT$15.32. GuruFocus considers Pharmosa Biopharm to be Significantly Overvalued.

Key valuation signals for ROCO:6875:

  • Defensive Interval Ratio:
  • GF Value™: NT$15.32 vs. price of NT$33.00 (115.4% above fair value)
  • GF Score™: 27/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6875 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharmosa Biopharm Business Description

Address No. 508, Sec. 7, Zhongxiao E. Road, 11th Floor / 11th Floor-1, Nangang District, Taipei, TWN
Pharmosa Biopharm Inc is a world-class biotechnology company. The Company's principal business activities comprise the development and commercialization of inventive biopharmaceutical drugs. Its product portfolio includes sustained-release dosage forms and drug-device combination products intended for home based therapies.
27GF Score

Get the complete analysis for ROCO:6875

Defensive Interval Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$33.00
Price
NT$15.32
GF Value